Clinical trialNCT05329103RecruitingPhase 1Interventional

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

SponsorPeel Therapeutics IncEnrollment65Advanced Solid Tumor

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Honorhealth Research Institiute
Scottsdale, Arizona, United States
Erkut Borazanci, MD
Recruiting
Stanford Cancer Center
Palo Alto, California, United States
Active, not recruiting
Carolina Biooncology Institute
Huntersville, North Carolina, United States
Completed
Abramson Cancer Center at Pennsylvania Hospital
Philadelphia, Pennsylvania, United States
Completed
Rhode Island Hospital
Providence, Rhode Island, United States
Howard Safran, MD
Recruiting
Mary Crowley Cancer Research
Dallas, Texas, United States
Completed
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Vaia Florou, MD
Recruiting
Next Virginia
Fairfax, Virginia, United States
Alexander Spira, MD, PhD, FACP
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

FOLF+BPEEL-224

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 11 Jul 2022
Primary completion: 31 Oct 2026
Completion: 31 Oct 2026
Last update posted: 15 May 2026
Registered enrollment: 65
Registry id: NCT05329103

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.